NasdaqCM - Nasdaq Real Time Price USD

Elutia Inc. (ELUT)

Compare
2.8650
+0.0950
+(3.54%)
As of 2:32:50 PM EDT. Market Open.
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
24,375
24,375
24,745
23,849
47,390
Cost of Revenue
13,668
13,668
13,692
12,210
28,368
Gross Profit
10,707
10,707
11,053
11,639
19,022
Operating Expense
34,990
34,990
31,590
41,628
41,778
Operating Income
-24,283
-24,283
-20,537
-29,989
-22,756
Net Non Operating Interest Income Expense
-4,779
-4,779
-5,796
-5,118
-5,324
Other Income Expense
-25,060
-25,060
-14,888
-1,041
3,303
Pretax Income
-54,122
-54,122
-41,221
-36,148
-24,777
Tax Provision
7
7
28
34
55
Net Income Common Stockholders
-53,949
-53,949
-37,656
-32,897
-24,832
Diluted NI Available to Com Stockholders
-53,949
-53,949
-37,656
-32,897
-24,832
Basic EPS
-1.86
--
-2.07
-2.38
-2.38
Diluted EPS
-1.86
--
-2.07
-2.38
-2.38
Basic Average Shares
29,071.1130
--
18,160.8220
13,832.8870
10,444.7670
Diluted Average Shares
29,071.1130
--
18,160.8220
13,832.8870
10,444.7670
Total Operating Income as Reported
-35,651
-35,651
-30,526
-35,189
-23,032
Total Expenses
48,658
48,658
45,282
53,838
70,146
Net Income from Continuing & Discontinued Operation
-53,949
-53,949
-37,656
-32,897
-24,832
Normalized Income
-33,394.6600
-33,394.6600
-30,087.0900
-32,074
-24,630.5200
Interest Expense
4,779
4,779
5,796
5,118
5,324
Net Interest Income
-4,779
-4,779
-5,796
-5,118
-5,324
EBIT
-49,343
-49,343
-35,425
-31,030
-19,453
EBITDA
-45,892
-45,892
-31,677
-27,297
-15,723
Reconciled Cost of Revenue
13,668
13,668
13,692
12,210
28,368
Reconciled Depreciation
3,451
3,451
3,748
3,733
3,730
Net Income from Continuing Operation Net Minority Interest
-54,129
-54,129
-41,249
-36,182
-24,832
Total Unusual Items Excluding Goodwill
-26,246
-26,246
-14,129
-5,200
-276
Total Unusual Items
-26,246
-26,246
-14,129
-5,200
-276
Normalized EBITDA
-19,646
-19,646
-17,548
-22,097
-15,447
Tax Rate for Calcs
0.0002
0.0002
0.0002
0.0002
0.0003
Tax Effect of Unusual Items
-5,511.6600
-5,511.6600
-2,967.0900
-1,092
-74.5200
12/31/2021 - 10/8/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

BVS Bioventus Inc.
9.03
-5.05%
 
TMCI Treace Medical Concepts, Inc.
7.86
-5.53%
 
TLSI TriSalus Life Sciences, Inc.
5.16
-6.69%
 
NPCE NeuroPace, Inc.
12.81
-5.39%
 
OFIX Orthofix Medical Inc.
15.66
-3.93%
 
TELA TELA Bio, Inc.
1.1850
-5.18%
 
XTNT Xtant Medical Holdings, Inc.
0.4701
+0.02%
 
KIDS OrthoPediatrics Corp.
24.20
-8.02%
 
SRDX Surmodics, Inc.
30.17
-1.92%
 
COCH Envoy Medical, Inc.
1.4150
+3.28%